Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Oct 31:36:72.
doi: 10.1186/1824-7288-36-72.

Refractory vasculitic ulcer of the toe in an adolescent suffering from systemic lupus erythematosus treated successfully with hyperbaric oxygen therapy

Affiliations
Case Reports

Refractory vasculitic ulcer of the toe in an adolescent suffering from systemic lupus erythematosus treated successfully with hyperbaric oxygen therapy

Alma N Olivieri et al. Ital J Pediatr. .

Abstract

Skin ulcers are a dangerous and uncommon complication of vasculitis. We describe the case of a teenager suffering from Systemic Lupus Erythematosus with digital ulcer resistant to conventional therapy, treated successfully with Hyperbaric Oxygen Therapy. The application of hyperbaric oxygen, which is used for the treatment of ischemic ulcers, is an effective and safe therapeutic option in patients with ischemic vasculitic ulcers in combination with immunosuppressive drugs. Further studies are needed to evaluate its role as primary therapy for this group of patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ulcer as it appears after 5 sessions of HBO.
Figure 2
Figure 2
Toes as they appear after 5 sessions of HBO.
Figure 3
Figure 3
Toe as it appears after 32 sessions of HBO therapy.

References

    1. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9(2):71–92. doi: 10.2165/00128071-200809020-00001. - DOI - PubMed
    1. Efrati S, Bergan J, Fishlev G, Tishler M, Golik A, Gall N. Hyperbaric oxygen therapy for nonhealing vasculitic ulcers. Clinical Exp Dermatol. 2007;32(1):12–7. - PubMed
    1. Zulian F, Costantini C, Montesco MC, Schiavon F, Zacchello F. Successful treatment of gangrene in systemic necrotizing vasculitis with iloprost. Br J Rheumatol. 1998;37(2):228–30. doi: 10.1093/rheumatology/37.2.228. - DOI - PubMed
    1. Zulian F, Corona F, Gerloni V, Falcini F, Buoncompagni A, Scarazatti M, Martini G, Zacchello F. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases. Rheumatology. 2004;43(2):229–33. doi: 10.1093/rheumatology/keg480. - DOI - PubMed
    1. Shouval DS, Mukamel M, Zulian F, Amir J, Harel L. Iloprost treatment for refractory Raynaud 's phenomenon in two infants. Clin Exp Rheumatol. 2008;26(Suppl 49):S105–S107. - PubMed

Publication types

Substances